Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 October 2020 | Story Thabo Kessah | Photo Supplied
Siphamandla Shabangu hopes to develop intercontinental networks during the Qatar University webinar.

“Assume you are in a leadership position, what can you do to improve the future of higher education?”
This is one of the questions Qwaqwa Campus SRC member, Siphamandla Shabangu, will be discussing during an international webinar to be hosted by Qatar University on Monday 5 October 2020. He will represent the University of the Free State, South Africa, and the African continent as a panellist to discuss the topic: Preparing for an Unpredictable Future: Global Insights from Higher Education Students. 

“Words to describe how it feels to represent not only my campus or institution, but the whole South African nation can never express this new feeling I have,” said Siphamandla. “I have never been afforded such an auspicious opportunity. This is indeed a new feeling for me, and I will do my best to turn it into a habit. I am honoured to have been selected to represent South Africa in a global academic and leadership space. I am a proud UFS ambassador and hope to one day become the face of the University of the Free State,” he added.

Tough selection process

Siphamandla revealed that the process of selection started with the Career Development office on campus. “I was selected among many greater minds on the Qwaqwa Campus. Fortunately, I further prospered among students across all three campuses of the University of the Free State, and finally became one of the best among the greats. Now, I am proud to be part of six unique panellists from different countries to unpack the impact of COVID-19 on institutions of higher learning. In fact, it is a prestigious honour to be the only African panellist – black African for that matter – in this global panel discussion,” he said.

Looking forward to the webinar

“I would very much like to acquire student lived experiences from countries outside the continent during the COVID-19 pandemic. I am also interested to know what methods of learning are sustainably applied at higher learning institutions from the perspectives of developing and highly developed countries. Moreover, I am eager to find out as to what leadership-inspired methods work best in different continents within the educational space that is gradually consumed by the Fourth Industrial Revolution. Furthermore, I am looking forward to developing international and intercontinental networks that will equip me to best explore opportunities across the globe. The academic space is dominated by intellects, visionaries, hustlers, lifelong learners, problem solvers, and even creative thinkers such as artists. However, it is within us to broaden the potential we have in life. It would be gratifying to know higher education systems from other prominent countries,” said Siphamandla.

The panel discussion will take place on Monday 5 October from 12:00 to13:00 (South African time). Other panellists are from the United Kingdom, Russia, Japan, Turkey, and Qatar. 

Siphamandla is currently serving as the SRC member responsible for Universal Access and Social Justice Council.

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept